| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC0260 |
| Trial ID | NCT02535364 |
| Disease | Acute Lymphoblastic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | JCAR015 |
| Phase | Phase2 |
| Recruitment status | Terminated |
| Title | Study Evaluating the Efficacy and Safety of JCAR015 in Adult B-cell Acute Lymphoblastic Leukemia (B-ALL) |
| Year | 2015 |
| Country | United States |
| Company sponsor | Juno Therapeutics, a Subsidiary of Celgene |
| Other ID(s) | 15001|JCAR015 |
| Cohort 1 | |||||||||||||||
|
|||||||||||||||